Skip to main content
Banu (Karimi) Karimi-Shah, MD, Pulmonology, Falls Church, VA

Banu Abbas (Karimi) Karimi-Shah MD

Pulmonology•Falls Church, VA

Critical Care Medicine, Pleural Disease

Physician

Join to View Full Profile

  • 3300 Gallows Road Department of MedicineFalls Church, VA 22042

  • Phone+1 703-776-3582

Are you Dr. Karimi-Shah?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Claim this profileNot you? Find your profile

Summary

  • Dr. Banu (Karimi) Karimi-Shah, MD is a pulmonologist in Falls Church, Virginia. She is currently licensed to practice medicine in Virginia.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical School
    Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2000

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2009 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • FDA Advisors Tepid on Drug Candidate for COVID Inpatients
    FDA Advisors Tepid on Drug Candidate for COVID InpatientsNovember 10th, 2022
  • FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations
    FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR MutationsJune 25th, 2019
  • FDA Expands Approval of CF Treatment to Include Patients Ages 6 and Older
    FDA Expands Approval of CF Treatment to Include Patients Ages 6 and OlderJune 24th, 2019
  • Join now to see all

Dr. Banu Karimi-Shah, Dr. Banu Karimi-Shah, MD, Dr. B Karimi-Shah, Dr. Banu Abbas Karimi-Shah